|
May 8
|
Jeff Auxier's Firm Dissolves Textainer Group Position, Trims Biogen
|
|
May 8
|
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
|
|
May 8
|
Q1 2024 Abcellera Biologics Inc Earnings Call
|
|
May 4
|
Morgan Stanley’s Top 15 Stock Picks for 2024
|
|
May 2
|
Biogen Reports Progress on Corporate Responsibility Priorities
|
|
May 1
|
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
|
Apr 29
|
7 Retirement Stocks to Buy at a 52-Week Low in April
|
|
Apr 29
|
10 Most Promising Stocks to Buy Before They Take Off
|
|
Apr 28
|
Biogen First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
|
Apr 27
|
Biogen Inc. (NASDAQ:BIIB) Just Released Its First-Quarter Earnings: Here's What Analysts Think
|
|
Apr 26
|
Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
|
|
Apr 26
|
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
|
|
Apr 26
|
Decoding Biogen Inc (BIIB): A Strategic SWOT Insight
|
|
Apr 25
|
Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®
|
|
Apr 25
|
Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
|
|
Apr 25
|
Biogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript
|
|
Apr 25
|
Shareholders 30% loss in Biogen (NASDAQ:BIIB) partly attributable to the company's decline in earnings over past year
|
|
Apr 25
|
For Beaten-Down Maker of Alzheimer’s Drug, Good Enough Will Do
|
|
Apr 25
|
Q1 2024 Biogen Inc Earnings Call
|
|
Apr 24
|
Why Biogen Stock Leaped Nearly 5% Higher Today
|